In addition, attenuation of the accumulation of pathological tau in the hippocampus was observed after 8 weeks of CEF treatment in the 3xTg-Alzheimer’s disease mouse model (Zumkehr et al., 2015). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.